10.03.2026

Alithea Bio: Featured in smartXhealth Startup Spotlight

ALITHEA BIO SMARTX

Alithea Bio: AI Meets Immunotherapy

Startup Spotlight: smartXhealth Newsletter

Alithea Biotechnology GmbH

We develop data-driven solutions for modern immunotherapies. By combining Immunopeptidomics, Mass Spectrometry, and AI-based Bioinformatics, we identify therapeutic targets with high precision.

Our cloud-based HLA-peptide database helps predict the efficacy and safety of new therapies early, reducing preclinical risks and shortening development cycles.

Alithea Bio Team

Trinationale Innovationskraft

Featured by smartXhealth and supported by BadenCampus, we are proud to represent the Freiburg start-up scene.

The recent BioCampus Upper Rhine Investor Day in Basel highlighted the growing importance of our trinationale innovation space. Explore the BioCampus Platform for more details.

Join us for smartXhealth connect in May 2026.


Contact smartXhealth Today

Read more

7th-TCR-Based-Therapies-Summit-logo-1-scaled-1.webp Aliteha bio

Alithea Bio to Join Industry Leaders at the 7th TCR-Based Therapies Summit in Boston

Read
Alisa Fuchs, PhD, German Innovation Award 2026

Alithea Bio Receives German Innovation Award 2026 for HLA-Compass Platform

Read
HLA binding prediction tool HLA-Compass AI Alithea Bio deep learning immunopeptidomics

HLA Binding Prediction: How Alithea Bio Outperforms MHCflurry 2.0

Read